Mayzent 1 mg film-coated tablets

DRUG2 trials

Sponsors

Antwerp University Hospital, Azienda Ospedaliera Universitaria Integrata Verona

Conditions

Active progressive multiple sclerosis course after an initial relapse clinical courseProgressive Multiple Sclerosis

Phase 2

Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placebo-controlled randomized clinical trial (MACSiMiSE-BRAIN)

Active, not recruitingCTIS2023-503190-38-00

Antwerp University HospitalProgressive Multiple Sclerosis

Start: 2023-11-23Target: 120Updated: 2025-11-07

Phase 4

Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis

RecruitingCTIS2024-518374-13-00

Azienda Ospedaliera Universitaria Integrata VeronaActive progressive multiple sclerosis course after an initial relapse clinical course

Start: 2022-02-28Target: 60Updated: 2024-11-05

Related Papers

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial

Frontiers in Immunology2024-02-2123 citations